Home
About
Overview
Sharing Data
ORCID
Help
History (45)
Immunoregulation in multiple sclerosis.
COVID-19 Conferences: Resident Perceptions of Online Synchronous Learning Environments.
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Concomitant Hip Arthroscopy and Periacetabular Osteotomy.
A drug safety evaluation of rituximab and risk of hepatitis B.
See All 45 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A drug safety evaluation of rituximab and risk of hepatitis B.
A drug safety evaluation of rituximab and risk of hepatitis B. Expert Opin Drug Saf. 2014 Jul; 13(7):977-87.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Antiviral Agents
Hepatitis B
Hepatitis B virus
Humans
Lymphoma, B-Cell
Rituximab
authors with profiles
Peter Riedell